Simplified molecular diagnosis of fragile X syndrome by fluorescent methylation-specific PCR and GeneScan analysis

Clinical Chemistry

Volumn 52, Issue 8, 2006, Pages 1492-1500

  Zhou, Youyou ^a,c   Lum, Josephine M S ^a   Yeo, Gare Hoon ^a   Kiing, Jennifer ^b   Tay, Stacey K H ^a,b   Chong, Samuel S ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; FLUORESCENT DYE; GENOMIC DNA;

5' UNTRANSLATED REGION; ARTICLE; CAPILLARY ELECTROPHORESIS; COMPUTER PROGRAM; CONTROLLED STUDY; DEVICE; DNA METHYLATION; DNA MODIFICATION; FMR1 GENE; FRAGILE X SYNDROME; GENE; GENOTYPE; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRINUCLEOTIDE REPEAT;

DNA METHYLATION; ELECTROPHORESIS, CAPILLARY; FEMALE; FLUORESCENT DYES; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; INDICATORS AND REAGENTS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; POLYMERASE CHAIN REACTION; SULFITES;

EID: 33746625983     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.068593     Document Type: Article

References (12)

1. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 1991;66:817-22.
2. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991;65:905-14.
3. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 1991;67: 1047-58.
4. Warren ST, Sherman SL. The fragile X syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease, Vol. 8. New York: McGraw Hill, 2001:1257-89.
5. Sutherland GR, Hecht F, Mulley JC, Glover TW, Hecht BK. The Fragile-X: Physical Phenotype. In: Sutherland GR, Hecht F, eds. Fragile Sites on Human Chromosomes. Oxford Monographs on Medical Genetics, No. 13. New York: Oxford University Press, 1985:132.
6. Oostra BA, Willemsen R. Diagnostic tests for fragile X syndrome. Expert Rev Mol Diagn 2001;1:226-32.
7. Zhou Y, Law HY, Boehm CD, Yoon CS, Cutting GR, Ng IS, Chong SS. Robust fragile X (CGG)n genotype classification using a methylation specific triple PCR assay. J Med Genet 2004;41:e45.
8. Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J, et al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med 1991;325:1673-81.
9. Warner JP, Barron LH, Goudie D, Kelly K, Dow D, Fitzpatrick DR, Brock DJ. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 1996;33:1022-6.
10. Hamdan H, Tynan JA, Fenwick RA, Leon JA. Automated detection of trinucleotide repeats in fragile X syndrome. Mol Diagn 1997;2: 259-69.
11. Larsen LA, Gronskov K, Norgaard-Pedersen B, Brondum-Nielsen K, Hasholt L, Vuust J. High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis. Hum Genet 1997;100: 564-8.
12. Houdayer C, Lemonnier A, Gerard M, Chauve C, Tredano M, de Villemeur TB, et al. Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus. Clin Chem Lab Med 1999;37:397-402.